VISION
Inspiring transformational change in the
field of oncology diagnostics
MISSION
To develop and deliver accurate, rapid, minimally
invasive oncology diagnostic products utilising our
patented MCM5 antibodies
Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Latest News
@ArquerDx
Calling all oncologists, urologists and radiation therapists! The Updates in #OncoUrology course is NEXT WEEK in be… https://t.co/E6cvaBdXB1
@ArquerDx
As the most common #cancer among #men, it pays to be one step ahead of #prostatecancer. If you have a family histor… https://t.co/3uKeyJJu9k
@ArquerDx
With just 1 week to go until the #BAUS Annual Scientific Meeting in #Liverpool, don't forget to register online via… https://t.co/lwwOUw6wWf